Stability chemistry
Peptide degradation pathways: oxidation, deamidation, hydrolysis and aggregation in research samples
By Vitality Chems · Published · updated · vendor-authored explanatory note
Short answer
Peptides degrade by a handful of well-characterized routes: oxidation of Met, Cys, Trp, His and Tyr; deamidation of Asn (fastest before Gly) and isomerization of Asp; cleavage of peptide bonds; cyclization of an N-terminal Gln or Glu to pyroglutamate; and physical aggregation. Most leave a fingerprint on LC-MS, such as +15.995 Da for oxidation or +0.984 Da for deamidation, while Asp isomerization changes no mass at all and shows up only as a new HPLC peak. Moisture, temperature, pH, light and trace metals are the main accelerators, which is why lyophilized material stored cold, dry and dark keeps longest.
Catalog materials discussed on this page
| Pathway | Residues or motifs | LC-MS signature | Accelerated by |
|---|---|---|---|
| Oxidation | Met (to sulfoxide), Cys, Trp, His, Tyr | +15.995 Da per oxygen (Met sulfoxide); disulfide formation −2.016 Da | Dissolved oxygen, peroxides, trace metal ions, light |
| Deamidation | Asn, especially Asn-Gly; Gln more slowly | +0.984 Da; often two new peaks (Asp and isoAsp forms) | Neutral to alkaline pH, temperature, moisture |
| Asp isomerization | Asp, especially Asp-Gly | No mass change (isobaric); new HPLC peak near the main peak | Neutral pH, temperature |
| Peptide-bond hydrolysis | Bonds next to Asp; Asn side-chain attack can cleave the chain | Two fragments whose masses sum to the parent plus 18.011 Da | Acidic pH (Asp), water, temperature |
| Pyroglutamate formation | N-terminal Gln or Glu | −17.027 Da from Gln (loss of NH3); −18.011 Da from Glu (loss of H2O) | Temperature, pH, time in solution |
| Diketopiperazine formation | N-terminal dipeptides, especially with Pro in position 2 | Loss of the first two residues as a cyclic dipeptide | Base, synthesis and storage conditions |
| Aggregation | Hydrophobic stretches, sequences near their pI | Loss of main-peak area, turbidity, high-mass species | Concentration, pH near pI, agitation, freeze-thaw |
Oxidation
Methionine, cysteine, histidine, tryptophan and tyrosine are the residues most susceptible to oxidation, because they react readily with reactive oxygen species. Oxidation can be driven by contaminating oxidants such as peroxides, catalyzed by transition metal ions, or induced by light, and it depends on pH, temperature and buffer composition (Li, Schöneich and Borchardt, 1995).
The two mechanisms behave differently. Oxidation by oxidants already in the solution can be suppressed with antioxidants or radical scavengers, but metal-catalyzed oxidation is site-specific and some antioxidants can speed it up; chelating agents are the alternative (Li et al., 1995). On a mass spectrum, methionine sulfoxide appears 15.995 Da above the parent for each oxygen added; two free cysteines forming a disulfide appear 2.016 Da lighter.
Deamidation and aspartate isomerization
Asparagine deamidation is one of the fastest chemical changes in peptides. In the model hexapeptide VYPNGA at 37 °C and pH 7.4, Geiger and Clarke measured deamidation through a succinimide intermediate with a characteristic time of only 1.4 days; the succinimide then hydrolyzed to a mixture of normal aspartyl and isoaspartyl peptides and also racemized. Replacing the Gly after Asn with a bulky Leu or Pro slowed degradation 33- to 50-fold (Geiger and Clarke, 1987).
pH changes the route as well as the rate. In acidic solution Asn-containing hexapeptides deamidated by direct hydrolysis to the Asp peptide only, while at neutral or alkaline pH they went through the cyclic imide and gave both isoAsp and Asp products; the residue on the C-terminal side of Asn controlled the rate at neutral to alkaline pH (Patel and Borchardt, 1990). Robinson and Robinson measured deamidation rates for 306 Asn sequences in model peptides at pH 7.4 and 37 °C, which is the standard reference for sequence effects (2001).
Deamidation adds 0.984 Da, which high-resolution LC-MS can resolve. Isomerization of Asp to isoAsp adds nothing, so it is invisible to an intact-mass check and appears only as a new, closely eluting HPLC peak. This is one reason purity by HPLC and identity by LC-MS answer different questions.
Hydrolysis, pyroglutamate and diketopiperazines
Peptide bonds can hydrolyze, especially next to aspartic acid under acidic conditions, giving two fragments whose masses add up to the parent plus one water (18.011 Da) (Manning, Patel and Borchardt, 1989). For slowly deamidating sequences, the Asn side chain can also attack the backbone and cleave the chain (Patel and Borchardt, 1990).
An N-terminal glutamine or glutamic acid can cyclize to pyroglutamate. From Gln this loses ammonia (−17.027 Da); from Glu it loses water (−18.011 Da). Chelius and colleagues documented pyroglutamate formation from N-terminal Glu in antibodies (2006).
Diketopiperazine formation removes the first two residues as a cyclic dipeptide. A process study of tirzepatide synthesis traced diketopiperazine formation, and the resulting double-amino-acid deletion impurities, to intermediates with a penultimate proline, and showed that lower storage temperature markedly improved intermediate stability (Wang et al., 2022). These deletion impurities are a reason to look for masses below the parent on an LC-MS report.
Aggregation and the solid state
Aggregation is a physical change: molecules associate into soluble oligomers or insoluble particles. It depends on concentration, pH relative to the isoelectric point, temperature, agitation and surfaces, and it can follow from chemical changes: metal-catalyzed oxidation induced aggregation and precipitation of human relaxin (Li et al., 1995b; Wang, 2005). It shows up as a falling main peak, turbidity, or species at multiples of the parent mass.
Lyophilization slows most of these reactions by removing water, but freezing and drying are stresses of their own, and solid material still has limited long-term stability (Wang, 2000). Residual moisture lets solid-state deamidation and oxidation continue, which is why vials should be warmed to room temperature before opening so that condensation does not form on the powder.
Reading degradation on a certificate of analysis
On an HPLC report, degradation appears as extra peaks and a lower area percent for the main peak. On an LC-MS report, compare the observed masses with the expected ones and with the shifts in the table above: a peak 16 Da heavy suggests oxidation, about 1 Da heavy suggests deamidation, and fragments suggest hydrolysis. Because a COA describes the lot on its test date, a report that is old relative to the material's storage history says less about the current state of the sample.
Related on Vitality Chems
- LC-MS identity testing — adducts, oxidation and deamidation shifts on a spectrum.
- Lyophilized peptide storage and handling — temperature, light, moisture and freeze-thaw.
- HPLC vs LC-MS — why isomerization needs chromatography.
- Expected m/z calculator — where the parent ions should appear.
- Spot a fake peptide COA — nine checks for any report.
- Semax lot documentation — a methionine-containing sequence (MEHFPGP).
Frequently asked
What is the most common way peptides degrade?
Oxidation of methionine and other susceptible residues, and deamidation of asparagine (fastest in Asn-Gly sequences), are the most frequently reported chemical routes. Aggregation is the most common physical one.
What mass shift does methionine oxidation cause on LC-MS?
+15.995 Da per oxygen atom added, giving methionine sulfoxide. A second oxidation to the sulfone adds another 15.995 Da.
Why can't LC-MS detect aspartate isomerization?
Isoaspartate has exactly the same mass as aspartate, so an intact-mass measurement cannot tell them apart. It is detected as a separate chromatographic peak or by specialized fragmentation methods.
Does lyophilization stop peptide degradation?
It slows it a great deal by removing water, but does not stop it. Residual moisture, heat, light and oxygen still drive slow solid-state reactions, so lyophilized material is best kept cold, dry and dark.
References
- Manning MC, Patel K, Borchardt RT. Stability of protein pharmaceuticals. Pharm Res. 1989;6(11):903-918. PMID 2687836Classic review of chemical and physical degradation routes, including hydrolysis and deamidation.
- Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. PMID 20143256Updated review of the same pathways.
- Li S, Schöneich C, Borchardt RT. Chemical instability of protein pharmaceuticals: mechanisms of oxidation and strategies for stabilization. Biotechnol Bioeng. 1995;48(5):490-500. PMID 18623513Residues most susceptible to oxidation; metal-catalyzed vs oxidant-driven mechanisms.
- Li S, Nguyen TH, Schöneich C, Borchardt RT. Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry. 1995. PMID 7727437Oxidation leading to aggregation (cited as Li et al., 1995b).
- Geiger T, Clarke S. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. J Biol Chem. 1987;262(2):785-794. PMID 3805008Succinimide route; 1.4-day deamidation of VYPNGA at 37 °C, pH 7.4; 33- to 50-fold slower with Leu or Pro after Asn.
- Patel K, Borchardt RT. Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides. Pharm Res. 1990;7(8):787-793. PMID 2235875Direct hydrolysis in acid vs cyclic imide at neutral and alkaline pH; backbone cleavage.
- Robinson NE, Robinson AB. Molecular clocks. Proc Natl Acad Sci U S A. 2001;98(3):944-949. PMID 11158575Deamidation rates of 306 Asn sequences at pH 7.4, 37 °C.
- Chelius D, et al. Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. Anal Chem. 2006. PMID 16579622Pyroglutamate formation from N-terminal Glu.
- Wang J, et al. Mechanistic study of diketopiperazine formation during solid-phase peptide synthesis of tirzepatide. ACS Omega. 2022;7(50):46809-46824. PMID 36570276Penultimate-proline intermediates, double-amino-acid deletion impurities, effect of storage temperature.
- Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm. 2005;289(1-2):1-30. PMID 15652195Mechanisms and factors affecting aggregation.
- Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. PMID 10967427Freezing and drying stresses; limited long-term stability in the solid state.
